Pharmacies are fed up with PBMs. Here’s what reforms might be coming
Outrage against PBMs was on full display when 400 pharmacy professionals in Kansas shuttered their businesses and petitioned ...
Pharmacy benefit management unicorn Capital Rx hits $3.5 billion in revenue with a different approach to drug pricing as Congress targets middlemen
Healthcare startup Capital Rx seeing revenue surge as Congress seeks to regulate the PBM giants that profit from high drug ...
After rough year, CVS set to report 2024 earnings
Investors in CVS Health Corp. (NYSE: CVS) will be looking for signs of improvement when the company's fourth-quarter and full-year earnings are released Wednesday morning ahead of the opening bell.